Log In
Print this Print this

rExendin-4 (rE-4)

  Manage Alerts
Collapse Summary General Information
Company Uni-Bio Science Group Ltd.
DescriptionGlucagon-like peptide-1 (GLP-1) homolog
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today